A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's
A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's
Active, not recruiting · NCT06928142 · Registry updated 2026-03-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's | Stomatognathic Diseases, Xerostomia, autoimmune disease, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, salivary gland disorder | Active, not recruiting | Phase 2 | 2026-03-18 | NCT06928142 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 26 |
64 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.